Danish bank eyes uncertainties for Demant in 2022

A sales halt of cochlear implants and predicted negative growth in France are behind some of the doubts about Demant’s 2022 guidance, writes an analyst from Jyske Bank.
Photo: Simon Fals
Photo: Simon Fals
by marketwire, translated by daniel pedersen

Danish bank Jyske Bank regards hearing aid manufacturer Demant’s half-year results from 2021 in a positive light, and therefore also the company’s full-year results, but several factors have caused some concerns about the company’s expectations for 2022, writes the bank’s senior equity analyst, Janne Vincent Kjær.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading